US Stock MarketDetailed Quotes

GRTX Galera Therapeutics

Watchlist

0.047
-0.004-7.92%

15min DelayClose Jan 8 16:00 ET

2.53MMarket Cap-0.16P/E (TTM)

Galera Therapeutics Stock Forum

Ultratech

Jan 3 23:51

$Galera Therapeutics (GRTX.US)$
insider bought 7,644,932 shares

Trytosaveabit

Jan 2 15:23

Insider buy

$Galera Therapeutics (GRTX.US)$ Nancy T Chang, 10% Owner, Director, on December 30, 2024, executed a purchase for 7,644,932 shares in Galera Therapeutics (GRTX) for $499,979. Following the Form 4 filing with the SEC, Chang has control over a total of 7,644,932 shares of the company, with 7,644,932 shares held directly.
SEC Filing:

Trytosaveabit

Oct 18, 2024 07:26

Grrr! New 8K Thanks SS’s

$Galera Therapeutics (GRTX.US)$ You got another one! not
Item 5.07.Submission of Matters to a Vote of Security Holders.
On October 17, 2024, Galera Therapeutics, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”). A total of 32,061,280 shares of common stock were present online or represented by proxy at the Special Meeting, representing approximately 58.94% percent of the Company’s outstanding common stock as of the August 27, 2024 record ...

Trytosaveabit

Jun 3, 2024 06:06

Grr

$Galera Therapeutics (GRTX.US)$ Galera Therapeutics Inc Says on May 31, Co Received Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined to Delist Co’s Shares on 6/4/2024 at trading open

Trytosaveabit

May 13, 2024 06:33

Nice EPS improvement

$Galera Therapeutics (GRTX.US)$ Galera reported a net loss of $(4.4) million, or $(0.08) per share, for the first quarter of 2024, compared to a net loss of $(17.7) million, or $(0.50) per share, for the same period in 2023.

Trytosaveabit

May 1, 2024 17:00

New Form 4

$Galera Therapeutics (GRTX.US)$ 10% Shareholder Schneid Yair purchased 2.78 million shares of common stock on Apr 17, 2014 and Apr 17, 18, 19, 2024 at an average price of $0.2124 for a total value of $590.42K.

Sean Parker

Apr 16, 2024 15:51

good stuff

$Galera Therapeutics (GRTX.US)$
Galera Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-ALPHA PHARMA INVESTMENTS LLC - EIN:(5.056%)